VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,262 | -61.8% | 10,807 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $265,096 | +14.5% | 10,807 | +8.6% | 0.00% | 0.0% |
| Q1 2023 | $231,536 | -0.1% | 9,950 | +7.0% | 0.00% | 0.0% |
| Q4 2022 | $231,806 | +20.7% | 9,302 | -6.4% | 0.00% | 0.0% |
| Q3 2022 | $192,000 | -24.1% | 9,943 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $253,000 | -1.6% | 9,943 | -0.4% | 0.00% | 0.0% |
| Q1 2022 | $257,000 | -30.2% | 9,983 | +6.8% | 0.00% | 0.0% |
| Q4 2021 | $368,000 | +21.5% | 9,348 | +34.2% | 0.00% | 0.0% |
| Q3 2021 | $303,000 | -5.6% | 6,965 | +2.7% | 0.00% | -50.0% |
| Q2 2021 | $321,000 | -52.9% | 6,781 | -49.0% | 0.00% | -50.0% |
| Q1 2021 | $682,000 | +189.0% | 13,296 | +51.1% | 0.00% | +100.0% |
| Q4 2020 | $236,000 | – | 8,799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |